Cargando…
Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
There is evidence that the α-synucleinopathies Parkinson's disease (PD) and the Parkinson variant of multiple system atrophy (MSA-P) overlap at multiple levels. Both disorders are characterized by deposition of abnormally phosphorylated fibrillar α-synuclein within the central nervous system su...
Autores principales: | Krismer, Florian, Jellinger, Kurt A., Scholz, Sonja W., Seppi, Klaus, Stefanova, Nadia, Antonini, Angelo, Poewe, Werner, Wenning, Gregor K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141743/ https://www.ncbi.nlm.nih.gov/pubmed/24894118 http://dx.doi.org/10.1016/j.parkreldis.2014.05.005 |
Ejemplares similares
-
Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014) -
Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013) -
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022) -
Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies
por: Bhattacharjee, Shakya, et al.
Publicado: (2022) -
Should the word ‘dementia’ be forgotten?
por: Jellinger, Kurt A
Publicado: (2010)